Tocotrienols for Obesity of Postmenopausal Women

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2025

Conditions
ObesityPostmenopausal Women
Interventions
DRUG

placebo softgel

Each placebo softgel of 430 mg olive oil will contain no TT or tocopherols at detectable levels.

DRUG

DeltaGold® Tocotrienol 70%

DeltaGold® Tocotrienol 70% contains 430 mg tocotrienol (90% δ-tocotrienol + 10% γ-tocotrienol) with a 70% purity, representing 300 mg tocotrienol.

Trial Locations (1)

79430

Texas Tech University Health Sciences Center, Lubbock

All Listed Sponsors
lead

Texas Tech University Health Sciences Center

OTHER

NCT03705845 - Tocotrienols for Obesity of Postmenopausal Women | Biotech Hunter | Biotech Hunter